Psychiatry Research
Volume 169, Issue 2 , Pages 124-131 , 30 September 2009

Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: Results of the BRITE-MD study

  • Andrew F. Leuchter

      Affiliations

    • Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, United States
    • Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States
    • Corresponding Author InformationCorresponding author. Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, 760 Westwood Plaza, Rm. 37-452, Los Angeles, CA 90024-1759, United States. Tel.: +1 310 825 0207; fax: +1 310 825 7642.
    • ,
  • Ian A. Cook

      Affiliations

    • Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, United States
    • Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States
    • ,
  • Lauren B. Marangell

      Affiliations

    • Department of Psychiatry, Baylor College of Medicine, Houston, TX, United States
    • ,
  • William S. Gilmer

      Affiliations

    • Department of Psychiatry, Northwestern University, Chicago, IL, United States
    • ,
  • Karl S. Burgoyne

      Affiliations

    • Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States
    • Department of Psychiatry, Harbor-UCLA Medical Center, Los Angeles, CA, United States
    • ,
  • Robert H. Howland

      Affiliations

    • Western Psychiatric Institute and Clinic, University of Pittsburgh, Pittsburgh, PA, United States
    • ,
  • Madhukar H. Trivedi

      Affiliations

    • Department of Psychiatry, University of Texas Southwestern Medical School, Dallas, TX, United States
    • ,
  • Sidney Zisook

      Affiliations

    • Department of Psychiatry, UCSD, San Diego, CA, United States
    • ,
  • Rakesh Jain

      Affiliations

    • Psychiatry, RD Clinical Research, Houston, TX, United States
    • ,
  • James T. McCracken

      Affiliations

    • Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States
    • ,
  • Maurizio Fava

      Affiliations

    • Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States
    • ,
  • Dan Iosifescu

      Affiliations

    • Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States
    • ,
  • Scott Greenwald

      Affiliations

    • Neuroscience, Aspect Medical Systems, Norwood, MA, United States

Received 15 January 2009 ,Revised 1 June 2009 ,Accepted 11 June 2009.

References 

  1. Anguelova M, Benkelfat C, Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior. Molecular Psychiatry. 2003;8(7):646–653
  2. Asada H, Fukuda Y, Tsunoda S, Yamaguchi M, Tonoike M. Frontal midline theta rhythms reflect alternative activation of prefrontal cortex and anterior cingulate cortex in humans. Neuroscience Letters. 1999;274:29–32
  3. Bearden CE, Freimer NB. Endophenotypes for psychiatric disorders: ready for primetime?. Trends in Genetics. 2006;22(6):306–313
  4. Cook IA, Leuchter AF, Morgan M, Witte E, Stubbeman WF, Abrams M, et al. Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology. 2002;27(1):120–131
  5. Crowell SE, Beauchaine TP, Gatzke-Kopp L, Sylvers P, Mead H, Chipman-Chacon J. Autonomic correlates of attention-deficit/hyperactivity disorder and oppositional defiant disorder in preschool children. Journal of Abnormal Psychology. 2006;115(1):174–178
  6. Cusin C, Serretti A, Zanardi R, Lattuada E, Rossini D, Lilli R, et al. Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity. Int J Neuropsychopharmacol. 2002;5(1):27–35
  7. Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR⁎D report. American Journal of Psychiatry. 2008;165(3):342–351
  8. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Research. 1975;12(3):189–198
  9. Greenberg PE, Kessler RC, Birnbaum HG, Leong SA, Lowe SW, Berglund PA, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000?. Journal of Clinical Psychiatry. 2003;64(12):1465–1475
  10. Guy W. ECDEU Assessment Manual for Psychopharmacology. U.S. Government Printing Office, U.S. Dept. of Health, Education and Welfare Publication No. 76-338. Superintendent of Documents, Government Printing Office, Washington, DC.; 1976;
  11. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery & Psychiatry. 1960;23:56–62
  12. Iosifescu DV, Greenwald SD, Smith CP, Devlin P, Alpert JE, Hamill S, et al. Frontal EEG at week 1 predicts clinical response to SSRI treatment in MDD. In: Presented as poster #231 at the Annual Meeting of the American Psychiatric Association. Toronto, Canada, May 20-25, 2006. 2006;
  13. Katon W, Robinson P, Von Korff M, Lin E, Bush T, Ludman E, et al. A multifaceted intervention to improve treatment of depression in primary care. Archives of General Psychiatry. 1996;53(10):924–932
  14. Katon W, Von Korff M, Lin E, Simon G, Walker E, Unutzer J, et al. Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Archives of General Psychiatry. 1999;56(12):1109–1115
  15. Kessler RC, Akiskal HS, Ames M, Birnbaum H, Greenberg P, Hirschfeld RM, et al. Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. American Journal of Psychiatry. 2006;163(9):1561–1568
  16. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). Journal of the American Medical Association. 2003;289(23):3095–3105
  17. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry. 1994;51(1):8–19
  18. Kim SJ, Cox N, Courchesne R, Lord C, Corsello C, Akshoomoff N, et al. Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder. Molecular Psychiatry. 2002;7(3):278–288
  19. Knott J, Telner JI, Lapierre YD, Browne M, Horn ER. Quantitative EEG in the prediction of antidepressant response to imipramine. Journal of Affective Disorders. 1996;39(3):175–184
  20. Konarski JZ, McIntyre RS, Soczynska JK, Kennedy SH. Neuroimaging approaches in mood disorders: technique and clinical implications. Annals of Clinical Psychiatry. 2007;19(4):265–277
  21. Leuchter AF, Kofol T, Greenwald SD, Devlin P, Cook IA. Source localization of anterior cingulate activity: comparison of 4 vs. 24 channel EEG techniques. In: Presented as poster at the Annual Meeting of the American Psychiatric Association. Atlanta, GA, USA, May 21-26, 2005. 2005;
  22. Leuchter AF, Marangell LB, Burgoyne KS, Sigl JC, Jain R, Zisook S, et al. Biomarkers for Rapid Identification of Treatment Effectiveness (BRITE): testing symptoms and biomarkers as predictors of response and remission in MDD. In: Presented as poster at the Annual Meeting of the American Psychiatric Association. Washington, D.C., USA. 2008;May 3-8
  23. Leuchter AF, Uijtdehaage SH, Cook IA, O'Hara R, Mandelkern M. Relationship between brain electrical activity and cortical perfusion in normal subjects. Psychiatry Research: Neuroimaging. 1999;90(2):125–140
  24. Malhotra AK, Murphy GM, Kennedy JL. Pharmacogenetics of psychotropic drug response. American Journal of Psychiatry. 2004;161(5):780–796
  25. McMahon FJ, Buervenich S, Charney D, Lipsky R, Rush AJ, Wilson AF, et al. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. American Journal of Human Genetics. 2006;78(5):804–814
  26. Papakostas GI, Thase ME, Fava M, Nelson JC, Shelton RC. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents. Biological Psychiatry. 2007;62(11):1217–1227
  27. Peters EJ, Slager SL, McGrath PJ, Knowles JA, Hamilton SP. Investigation of serotonin-related genes in antidepressant response. Molecular Psychiatry. 2004;9(9):879–889
  28. Poland R, Greenwald SD, Smith CP, Kustak C, Schulz J, Rowe S, et al. Frontal EEG at 1 week predicts response to treatment with citalopram in MDD. In: Presented as poster at the Annual Meeting of the American Psychiatric Association. Toronto, Canada, May 20-25, 2006. 2006;
  29. Posternak MA, Zimmerman M. Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: meta-analysis. British Journal of Psychiatry. 2007;190:287–292
  30. Rasmussen BB, Brosen K. Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors?. Therapeutic Drug Monitoring. 2000;22(2):143–154
  31. Rush AJ. The varied clinical presentations of major depressive disorder. Journal of Clinical Psychiatry. 2007;68(Suppl 8):4–10
  32. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychological Medicine. 1996;26(3):477–486
  33. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biological Psychiatry. 2003;54(5):573–583
  34. Sheehan DV, Lecrubier Y, Harnett-Sheehan K, Janavs J, Weiller E, Bonara LI, et al. Reliability and validity of the MINI International Neuropsychiatric Interview (M.I.N.I.): according to the SCID-P. European Psychiatry. 1997;12:232–241
  35. Small GW, Hamilton SH, Bystritsky A, Meyers BS, Nemeroff CB. Clinical response predictors in a double-blind, placebo-controlled trial of fluoxetine for geriatric major depression. Fluoxetine Collaborative Study Group. International Psychogeriatrics. 1995;7:41–53Suppl
  36. Trivedi MH, Rush AJ, Crismon ML, Kashner TM, Toprac MG, Carmody TJ, et al. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Archives of General Psychiatry. 2004;61(7):669–680
  37. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR⁎D: implications for clinical practice. American Journal of Psychiatry. 2006;163(1):28–40
  38. Ulrich G, Haug HJ, Fahndrich E. Acute vs. chronic EEG effects in maprotiline- and in clomipramine-treated depressive inpatients and the prediction of therapeutic outcome. Journal of Affective Disorders. 1994;32(3):213–217
  39. Ulrich G, Haug HJ, Stieglitz RD, Fahndrich E. Are there distinct biochemical subtypes of depression? EEG characteristics of clinically defined on-drug responders and non-responders. Journal of Affective Disorders. 1988;15(2):181–185

PII: S0165-1781(09)00212-1

doi: 10.1016/j.psychres.2009.06.004

Psychiatry Research
Volume 169, Issue 2 , Pages 124-131 , 30 September 2009

Article Tools

* Image Usage & Resolution